BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

openQ Announces the Release of openIIS 2.5


5/27/2010 11:19:22 AM

Charlottesville, VA, San Francisco, CA, New York, NY and Paris, France –May 27, 2010 – Building on their previous releases, openQ has released an expanded offering for managing Investigator Initiated Studies/ Trials (IIS/IIT). openIIS 2.5 provides a broad set of tools to manage the complete IIS lifecycle, from study submission and internal review, to study closeout.

openIIS is designed from the ground up to support regulatory compliance in an era of increasing federal scrutiny. Transparent customer business processes, through clearly documented and extensive audit trails, provide customers with complete access to decision criteria - including who reviewed the application, when they reviewed it, and why they made their decision. Expanded reporting functionally provides insight into studies, supporting critical areas such as financial controls.

While openIIS comes pre-configured with best practices gleaned from openQ’s industry experience, this doesn’t mean that customers are forced into a constrictive environment. The system also provides a configurable workflow engine to give customers the flexibility to configure the software to match their standard operating procedures. “Despite its broad feature set and business process flexibility, we wanted to make openIIS easy to use,” said Matt Prentis, Director of Product Management at openQ. “Leveraging easily accessible portals for external investigators and internal users, along with submission wizards to guide investigators as they navigate the submission process help provide a smooth user experience. Additionally, key functionality to support multi-company sponsored grants simplifies even the more complex management tasks.”

openIIS is part of a broad portfolio of software and data offerings that openQ provides to Life Sciences companies. openQ provides solutions in KOL Management, Medical Affairs Programs, Grant Funding & Study Management, and Speaker Programs.

About openQ

Based in Charlottesville, Virginia, openQ helps Life Sciences companies manage compliant business processes in their Marketing and Medical Affairs organizations. openQ’s solutions currently support compliance initiatives at 8 of the Top 10 Pharmaceutical and 3 of the Top 5 Medical Device Companies. For more information, visit www.openq.com.


Read at BioSpace.com

OpenQ
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES